advertisement
Abstract #13549 Published in IGR 8-1
Outcomes of inferonasal Baerveldt glaucoma drainage implant surgery
Harbick KH; Sidoti PA; Budenz DL; Venkatraman A; Bruther M; Grayson DK; Ko A; Yi GNJournal of Glaucoma 2006; 15: 7-12
PURPOSE: To determine the outcomes of inferonasal Baerveldt glaucoma implant (BGI) surgery. PATIENTS AND METHODS: A retrospective, non-comparative case series of 182 eyes of 182 patients who underwent inferonasal placement of a Baerveldt glaucoma implant. The main outcome measures included intraocular pressure, number of glaucoma medications, best corrected visual acuity, and complications. RESULTS: Patients were followed for an average (± SD) of 19 ± 15 months. Median Snellen visual acuity was unchanged at last follow-up. Intraocular pressure was reduced from a mean (± SD) of 28.6 ± 11.5 mmHg preoperatively to 13.4 ± 5.7 mmHg at most recent follow-up (P < 0.001). The number of antiglaucoma medications was reduced from a mean (± SD) of 2.7 ± 1.3 preoperatively to 1.1 ± 1.1 at most recent follow-up. Nineteen eyes met our criteria for failure, yielding a cumulative percent survival of 92% at 12 months, 88% at 24 months, and 77% at 44 months. The most common complications were hyphema (14 eyes, 8%), choroidal effusion (12 eyes, 7%), and corneal decompensation (19 eyes, 10%). Endophthalmitis and diplopia occurred rarely (1 eye, < 1%; 3 eyes, 2%, respectively). CONCLUSIONS: Inferonasal Baerveldt glaucoma implant placement appears to be a safe and effective surgical option that may be helpful in certain clinical situations.
Dr. K.H. Harbick, Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, FL, USA
Classification:
12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
